| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.143.743 | 7.403.291 | 7.349.846 | 6.232.116 | 4.843.456 | 3.880.735 | 3.441.122 | 1.399.977 | 992.772 | 107.914 |
| Total Income - EUR | 10.362.438 | 7.544.499 | 7.477.659 | 6.270.558 | 4.933.009 | 3.911.278 | 3.474.333 | 1.433.247 | 1.009.199 | 268.343 |
| Total Expenses - EUR | 9.356.687 | 6.623.911 | 6.703.047 | 6.267.364 | 5.255.868 | 4.449.405 | 3.956.247 | 1.824.450 | 1.448.581 | 974.719 |
| Gross Profit/Loss - EUR | 1.005.752 | 920.588 | 774.612 | 3.194 | -322.859 | -538.127 | -481.914 | -391.202 | -439.382 | -706.376 |
| Net Profit/Loss - EUR | 829.305 | 751.760 | 640.184 | -7.751 | -322.859 | -538.127 | -481.914 | -391.202 | -439.382 | -706.376 |
| Employees | 114 | 96 | 108 | 112 | 97 | 87 | 66 | 38 | 30 | 7 |
Check the financial reports for the company - Vavian Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 160.915 | 116.703 | 181.471 | 270.185 | 175.214 | 96.306 | 52.994 | 26.324 | 15.492 | 338 |
| Current Assets | 5.645.491 | 5.395.367 | 5.428.120 | 4.089.454 | 3.509.133 | 2.602.088 | 2.564.069 | 1.369.674 | 1.121.372 | 215.010 |
| Inventories | 1.344.463 | 1.661.866 | 2.383.506 | 2.002.674 | 1.397.029 | 824.305 | 947.138 | 590.635 | 519.091 | 0 |
| Receivables | 2.580.327 | 1.844.693 | 2.376.327 | 1.837.593 | 1.565.281 | 1.373.661 | 1.259.100 | 720.501 | 591.536 | 192.722 |
| Cash | 1.596.316 | 1.776.507 | 570.544 | 234.841 | 542.298 | 403.793 | 354.117 | 57.589 | 10.745 | 22.288 |
| Shareholders Funds | 3.708.357 | 4.034.369 | 3.310.341 | 3.014.995 | 2.633.747 | 2.045.691 | 1.518.421 | 1.131.929 | 689.115 | -21.112 |
| Social Capital | 11.249 | 11.134 | 10.945 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 10.108 | 10.052 |
| Debts | 2.111.634 | 1.493.028 | 2.315.083 | 1.345.749 | 1.056.525 | 657.610 | 1.104.022 | 264.552 | 447.749 | 236.460 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Vavian Pharma Srl